Viveve Medical, Inc. (VIVE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2021 | -2.65 USD | 83.26% |
| 2020 | -13.50 USD | 96.39% |
| 2019 | -374.40 USD | 76.36% |
| 2018 | -1583.50 USD | 24.37% |
| 2017 | -2093.62 USD | 4.0% |
| 2016 | -2180.76 USD | 11.86% |
| 2015 | -2474.31 USD | 9.84% |
| 2014 | -2744.23 USD | -112.24% |
| 2013 | 22.42 Thousand USD | 110.7% |
| 2012 | -209.67 Thousand USD | -34.73% |
| 2011 | -155.62 Thousand USD | -1040.2% |
| 2010 | -13.64 Thousand USD | 68.94% |
| 2009 | -43.94 Thousand USD | 16.19% |
| 2008 | -52.43 Thousand USD | 18.04% |
| 2007 | -63.97 Thousand USD | -279.46% |
| 2006 | 35.64 Thousand USD | 204.02% |
| 2005 | -34.27 Thousand USD | -52.22% |
| 2004 | -22.51 Thousand USD | -261.13% |
| 2003 | 13.97 Thousand USD | 69.5% |
| 2002 | 8243.24 USD | 107.61% |
| 2001 | -108.38 Thousand USD | 57.58% |
| 2000 | -255.51 Thousand USD | -1.35% |
| 1999 | -252.11 Thousand USD | 62.03% |
| 1998 | -664 Thousand USD | -6.06% |
| 1997 | -626.08 Thousand USD | -734.78% |
| 1996 | -75 Thousand USD | -172.12% |
| 1995 | 104 Thousand USD | 176.0% |
| 1994 | -136.84 Thousand USD | 45.26% |
| 1993 | -250 Thousand USD | 86.65% |
| 1992 | -1.87 Million USD | -877.39% |
| 1991 | -191.66 Thousand USD | -2200.0% |
| 1990 | -8333.33 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 Q3 | -0.50 USD | 13.79% |
| 2022 Q2 | -0.58 USD | 0.0% |
| 2022 Q1 | -0.58 USD | 7.94% |
| 2021 Q2 | -0.39 USD | 41.79% |
| 2021 Q3 | -0.55 USD | -41.03% |
| 2021 Q4 | -0.63 USD | -14.55% |
| 2021 FY | - USD | 83.26% |
| 2021 Q1 | -0.67 USD | 69.41% |
| 2020 Q3 | -2.07 USD | 58.76% |
| 2020 Q1 | -7.07 USD | 66.24% |
| 2020 Q2 | -5.02 USD | 29.0% |
| 2020 Q4 | -2.19 USD | -5.8% |
| 2020 FY | - USD | 96.39% |
| 2019 Q3 | -135.08 USD | 35.45% |
| 2019 Q1 | -216.28 USD | 43.12% |
| 2019 Q4 | -20.94 USD | 84.5% |
| 2019 Q2 | -209.28 USD | 3.24% |
| 2019 FY | - USD | 76.36% |
| 2018 Q3 | -390.74 USD | -6.22% |
| 2018 Q1 | -490.17 USD | 6.82% |
| 2018 Q2 | -367.86 USD | 24.95% |
| 2018 FY | - USD | 24.37% |
| 2018 Q4 | -380.23 USD | 2.69% |
| 2017 Q1 | -574.04 USD | -5.07% |
| 2017 FY | - USD | 4.0% |
| 2017 Q4 | -526.06 USD | -6.19% |
| 2017 Q3 | -495.41 USD | 7.94% |
| 2017 Q2 | -538.12 USD | 6.26% |
| 2016 Q3 | -458.04 USD | 30.38% |
| 2016 Q4 | -546.32 USD | -19.27% |
| 2016 Q1 | -547.98 USD | -2.23% |
| 2016 Q2 | -657.92 USD | -20.06% |
| 2016 FY | - USD | 11.86% |
| 2015 Q2 | -674.90 USD | 38.69% |
| 2015 Q3 | -501.56 USD | 25.68% |
| 2015 Q1 | -1100.74 USD | -42.25% |
| 2015 FY | - USD | 9.84% |
| 2015 Q4 | -536.01 USD | -6.87% |
| 2014 Q3 | -1111.97 USD | -110.5% |
| 2014 FY | - USD | -112.24% |
| 2014 Q1 | -15.46 Thousand USD | -160.73% |
| 2014 Q2 | 10.58 Thousand USD | 168.47% |
| 2014 Q4 | -773.80 USD | 30.41% |
| 2013 Q3 | -3903.85 USD | -104.08% |
| 2013 Q1 | -113.15 Thousand USD | -250.83% |
| 2013 FY | - USD | 110.7% |
| 2013 Q4 | 25.46 Thousand USD | 752.2% |
| 2013 Q2 | 95.73 Thousand USD | 184.6% |
| 2012 Q3 | -81.15 Thousand USD | -113.56% |
| 2012 Q2 | -38 Thousand USD | 78.7% |
| 2012 Q1 | -178.39 Thousand USD | -541.46% |
| 2012 FY | - USD | -34.73% |
| 2012 Q4 | 75.02 Thousand USD | 192.45% |
| 2011 Q4 | -27.81 Thousand USD | -156.61% |
| 2011 FY | - USD | -1040.2% |
| 2011 Q2 | -14.62 Thousand USD | 85.71% |
| 2011 Q1 | -102.35 Thousand USD | -1562.16% |
| 2011 Q3 | -10.83 Thousand USD | 25.88% |
| 2010 FY | - USD | 68.94% |
| 2010 Q3 | -135.14 USD | 97.49% |
| 2010 Q1 | -15.16 Thousand USD | 6.97% |
| 2010 Q2 | -5378.38 USD | 64.53% |
| 2010 Q4 | 7000.00 USD | 5279.81% |
| 2009 Q3 | -9675.68 USD | -16.61% |
| 2009 Q1 | -9675.68 USD | -61.26% |
| 2009 Q4 | -16.29 Thousand USD | -68.44% |
| 2009 FY | - USD | 16.19% |
| 2009 Q2 | -8297.30 USD | 14.25% |
| 2008 Q1 | -20.59 Thousand USD | 6.96% |
| 2008 FY | - USD | 18.04% |
| 2008 Q4 | -6000.00 USD | 22.11% |
| 2008 Q3 | -7702.70 USD | 57.53% |
| 2008 Q2 | -18.13 Thousand USD | 11.94% |
| 2007 FY | - USD | -279.46% |
| 2007 Q4 | -22.13 Thousand USD | -64.13% |
| 2007 Q2 | -9810.81 USD | 47.08% |
| 2007 Q1 | -18.54 Thousand USD | -2005.56% |
| 2007 Q3 | -13.48 Thousand USD | -37.47% |
| 2006 Q2 | 1945.95 USD | -94.42% |
| 2006 FY | - USD | 204.02% |
| 2006 Q1 | 34.89 Thousand USD | 425.18% |
| 2006 Q4 | 972.97 USD | 145.0% |
| 2006 Q3 | -2162.16 USD | -211.11% |
| 2005 FY | - USD | -52.22% |
| 2005 Q4 | -10.72 Thousand USD | 0.0% |
| 2005 Q3 | -10.72 Thousand USD | -36.9% |
| 2005 Q1 | -4972.97 USD | -190.2% |
| 2005 Q2 | -7837.84 USD | -57.61% |
| 2004 Q3 | -11.78 Thousand USD | -73.71% |
| 2004 Q2 | -6783.78 USD | 28.29% |
| 2004 Q1 | -9459.46 USD | -572.97% |
| 2004 FY | - USD | -261.13% |
| 2004 Q4 | 5513.51 USD | 146.79% |
| 2003 Q2 | 5486.49 USD | 1253.32% |
| 2003 FY | - USD | 69.5% |
| 2003 Q3 | 6081.08 USD | 10.84% |
| 2003 Q4 | 2000.00 USD | -67.11% |
| 2003 Q1 | 405.41 USD | -92.86% |
| 2002 Q4 | 5675.68 USD | -4.11% |
| 2002 FY | - USD | 107.61% |
| 2002 Q3 | 5918.92 USD | 62.22% |
| 2002 Q2 | 3648.65 USD | 152.12% |
| 2002 Q1 | -7000.00 USD | 57.86% |
| 2001 Q4 | -16.61 Thousand USD | 39.47% |
| 2001 Q3 | -27.44 Thousand USD | 13.33% |
| 2001 Q2 | -31.66 Thousand USD | 3.06% |
| 2001 Q1 | -32.66 Thousand USD | 68.71% |
| 2001 FY | - USD | 57.58% |
| 2000 Q1 | -83.96 Thousand USD | -73.94% |
| 2000 Q2 | -30.41 Thousand USD | 63.78% |
| 2000 Q3 | -45.41 Thousand USD | -49.32% |
| 2000 Q4 | -104.41 Thousand USD | -129.92% |
| 2000 FY | - USD | -1.35% |
| 1999 Q4 | -48.26 Thousand USD | -761.95% |
| 1999 Q3 | -5600.00 USD | 91.76% |
| 1999 Q2 | -68 Thousand USD | 22.73% |
| 1999 Q1 | -88 Thousand USD | 33.33% |
| 1999 FY | - USD | 62.03% |
| 1998 Q1 | -169.56 Thousand USD | 23.53% |
| 1998 Q3 | -16.8 Thousand USD | 92.84% |
| 1998 Q4 | -132 Thousand USD | -685.4% |
| 1998 FY | - USD | -6.06% |
| 1998 Q2 | -234.78 Thousand USD | -38.46% |
| 1997 Q2 | -135 Thousand USD | 10.0% |
| 1997 Q3 | -168.00 USD | 99.88% |
| 1997 FY | - USD | -734.78% |
| 1997 Q1 | -150 Thousand USD | -130.77% |
| 1997 Q4 | -221.73 Thousand USD | -131887.58% |
| 1996 Q1 | 64 Thousand USD | -62.0% |
| 1996 Q4 | -65 Thousand USD | -116.67% |
| 1996 Q3 | -30 Thousand USD | 33.33% |
| 1996 Q2 | -45 Thousand USD | -170.31% |
| 1996 FY | - USD | -172.12% |
| 1995 Q2 | -31.57 Thousand USD | -494.74% |
| 1995 Q3 | -42.1 Thousand USD | -33.33% |
| 1995 Q4 | 168.42 Thousand USD | 500.0% |
| 1995 Q1 | 8000.00 USD | 138.0% |
| 1995 FY | - USD | 176.0% |
| 1994 Q1 | -43.75 Thousand USD | 22.22% |
| 1994 FY | - USD | 45.26% |
| 1994 Q3 | -47.36 Thousand USD | -26.32% |
| 1994 Q4 | -21.05 Thousand USD | 55.56% |
| 1994 Q2 | -37.5 Thousand USD | 14.29% |
| 1993 Q4 | -56.25 Thousand USD | 0.0% |
| 1993 FY | - USD | 86.65% |
| 1993 Q1 | -60 Thousand USD | 10.0% |
| 1993 Q2 | -81.25 Thousand USD | -35.42% |
| 1993 Q3 | -56.25 Thousand USD | 30.77% |
| 1992 Q4 | -66.66 Thousand USD | 6.67% |
| 1992 Q1 | -2.09 Million USD | -4083.33% |
| 1992 Q3 | -71.42 Thousand USD | -3.17% |
| 1992 Q2 | -69.23 Thousand USD | 96.69% |
| 1992 FY | - USD | -877.39% |
| 1991 Q4 | -50 Thousand USD | 0.0% |
| 1991 Q2 | -50 Thousand USD | -20.0% |
| 1991 Q3 | -50 Thousand USD | 0.0% |
| 1991 Q1 | -41.66 Thousand USD | 0.0% |
| 1991 FY | - USD | -2200.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q3 | -8000.00 USD | 0.0% |
| 1990 Q2 | -8000.00 USD | 4.0% |
| 1990 Q1 | -8333.33 USD | 0.0% |
| 1990 Q4 | - USD | 100.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Acutus Medical, Inc. | -2.81 USD | 5.694% |
| Biotricity, Inc. | -1.66 USD | -59.639% |
| Cell MedX Corp. | -0.00 USD | -529900.0% |
| Dynatronics Corporation | -1.00 USD | -165.0% |
| Nemaura Medical Inc. | -0.57 USD | -364.912% |
| PetVivo Holdings, Inc. | -0.78 USD | -239.744% |
| RetinalGenix Technologies Inc. | -0.12 USD | -2108.333% |
| Sonendo, Inc. | -0.65 USD | -307.692% |
| Telesis Bio, Inc. | -1.64 USD | -61.585% |
| Talis Biomedical Corporation | -34.12 USD | 92.233% |